Clinical trial
Prospective Biomarkers of Bone Metabolism in Hemophilia A
NCT02306694 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Biomarkers of Bone Metabolism in Hemophilia A
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- April 16, 2018
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone disease, hemophilia